March 26, 2024 Issue of JAMA

March 26, 2024, Vol 331, No. 12, Pages 993-1070

In This Issue of JAMA

Audio Highlights

Abstract Full Text

free access online only has audio

JAMA. 2024;331(12):e2318241. doi:10.1001/jama.2023.18241

Audio: Paclitaxel-Coated Balloon for Coronary In-Stent Restenosis, Linkage Case Management for HIV Care, Review of Common Oral Conditions, and more

Original Investigation

Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis: The AGENT IDE Randomized Clinical Trial

Robert W. Yeh, MD, MSc; Richard Shlofmitz, MD; Jeffrey Moses, MD; et al.

Abstract Full Text

free access

JAMA. 2024;331(12):1015-1024. doi:10.1001/jama.2024.1361

This clinical trial compares a paclitaxel-coated balloon vs an uncoated balloon in patients with in-stent restenosis undergoing percutaneous coronary intervention.

Editorial
Drug-Coated Balloons for In-Stent Restenosis鈥擣inally Leaving Nothing Behind for US Patients
Amartya Kundu, MD; David J. Moliterno, MD

JAMA

Linkage Case Management and Posthospitalization Outcomes in People With HIV: The Daraja Randomized Clinical Trial

Robert N. Peck, MD, PhD; Benson Issarow, MD; Godfrey A. Kisigo, MD, MSc; et al.

Abstract Full Text

has active quiz

JAMA. 2024;331(12):1025-1034. doi:10.1001/jama.2024.2177

This randomized trial assesses whether a linkage case management intervention reduces 12-month mortality compared with enhanced standard care among people with HIV not taking antiretroviral therapy (ART) who were hospitalized for any reason.

Editorial
A Linkage-to-Care Intervention for Hospitalized People With HIV: High Value at Minimal Cost
K. Rivet Amico, PhD

JAMA

Effect of Early vs Late Inguinal Hernia Repair on Serious Adverse Event Rates in Preterm Infants: A Randomized Clinical Trial

HIP Trial Investigators

Abstract Full Text

JAMA. 2024;331(12):1035-1044. doi:10.1001/jama.2024.2302

This randomized clinical trial compares the safety of early (before discharge from the neonatal intensive care unit) vs later inguinal hernia repair among infants born prematurely who underwent the procedure near the end of their neonatal intensive care unit stay.

Research Letter

Adverse Events After XBB.1.5-Containing COVID-19 mRNA Vaccines

Niklas Worm Andersson, MD; Emilia Myrup Thiesson, MSc; Anders Hviid, DrMedSci

Abstract Full Text

free access

JAMA. 2024;331(12):1057-1059. doi:10.1001/jama.2024.1036

This study examines the association between XBB.1.5-containing vaccines administered as a fifth COVID-19 vaccine dose and the risk of 28 adverse events.

Rate of Aquatic and Maritime Drowning Deaths After US-Mexico Border Wall Height Increase

Anna Lussier, BA; Peter Lindholm, MD, PhD

Abstract Full Text

JAMA. 2024;331(12):1059-1060. doi:10.1001/jama.2024.1275

This study assesses migratory drowning deaths along the southwest border of the US before and after the increase in border wall height.

Viewpoint

Direct-to-Consumer Drug Company Pharmacies

Benjamin N. Rome, MD, MPH

Abstract Full Text

JAMA. 2024;331(12):1003-1004. doi:10.1001/jama.2024.2911

The recent launch of direct-to-consumer pharmacy LillyDirect prompts the author of this Viewpoint to consider why it was created and also to raise concerns about allowing manufacturers to sell their drugs directly to patients.

Misinformation and the Vaccine Adverse Event Reporting System

Kathleen Hall Jamieson, PhD; Kevin B. Johnson, MD, MS; Anne R. Cappola, MD, ScM

Abstract Full Text

JAMA. 2024;331(12):1005-1006. doi:10.1001/jama.2024.1757

This Viewpoint posits that to improve public understanding of the system, the Vaccine Adverse Event Reporting System (VAERS) could use a more accurate name, well-defined guidance about the reporting system鈥檚 nature and use, and comprehensible information about an event鈥檚 verification status.

Editorial
Postmarketing Vaccine Safety Assessments: Important Work in Progress
Kathryn M. Edwards, MD; Marie R. Griffin, MD, MPH

JAMA

GLP-1 Agonists for Obesity鈥擜 New Recipe for Success?

Dariush Mozaffarian, MD, DrPH

Abstract Full Text

JAMA. 2024;331(12):1007-1008. doi:10.1001/jama.2024.2252

This Viewpoint discusses the drawbacks of using glucagon-like peptide 1 (GLP-1) agonists to treat obesity and presents an alternative approach of initial, staged GLP-1 agonist treatment supported by long-term lifestyle programming, including medically appropriate groceries or meals (鈥淔ood Is Medicine鈥�), to address the cost, health, and equity burdens of obesity.

A Piece of My Mind

Something鈥檚 Not Quite Right

Tessa Ad啪emovi膰, MD, MS

Abstract Full Text

JAMA. 2024;331(12):1009-1010. doi:10.1001/jama.2024.1257

In this narrative medicine essay, a physician recalls that when she presented with a suspected appendicitis as a medical student, she repeatedly requested a confirmation CT scan, which revealed a different diagnosis, and relates her experience with those of many women whose symptoms are not thoroughly checked out.

Editorial

Drug-Coated Balloons for In-Stent Restenosis鈥擣inally Leaving Nothing Behind for US Patients

Amartya Kundu, MD; David J. Moliterno, MD

Abstract Full Text

free access

JAMA. 2024;331(12):1011-1012. doi:10.1001/jama.2024.0813

A Linkage-to-Care Intervention for Hospitalized People With HIV: High Value at Minimal Cost

K. Rivet Amico, PhD

Abstract Full Text

JAMA. 2024;331(12):1013-1014. doi:10.1001/jama.2024.0271

Review

Common Oral Conditions: A Review

Eric T. Stoopler, DMD; Alessandro Villa, DDS, PhD, MPH; Mohammed Bindakhil, DDS, MS; et al.

Abstract Full Text

has active quiz has audio

JAMA. 2024;331(12):1045-1054. doi:10.1001/jama.2024.0953

This review discusses diagnosis and first-line treatment options for dry mouth, oral candidiasis, and recurrent aphthous ulcers.

Audio: Diagnoses and Treatment of Common Oral Conditions

JAMA Clinical Guidelines Synopsis

Disease-Modifying Drugs for Adult-Onset Rheumatoid Arthritis

Maya N. Faison, MD; Andrew M. Davis, MD, MPH; Kimberly C. Trotter, MD

Abstract Full Text

has active quiz

JAMA. 2024;331(12):1055-1056. doi:10.1001/jama.2023.26504

This article summarizes a 2022 clinical practice guideline on the use of disease-modifying antirheumatic drugs (DMARDs) for adults with rheumatoid arthritis from the European League Against Rheumatism (EULAR).

Editor's Note

Waiting Room

Gary Stein, MFA, JD

Abstract Full Text

JAMA. 2024;331(12):1066. doi:10.1001/jama.2024.0238

Editor's Note
The Waiting Room, Revisited
Rafael Campo, MD, MA

JAMA

JAMA Revisited

The Clinical Teacher and the Medical Curriculum: Harvey Cushing, M.D., Professor of Surgery, Medical School of Harvard University, Boston

Abstract Full Text

JAMA. 2024;331(12):1067. doi:10.1001/jama.2023.18235

JAMA Patient Page

What Is Cushing Syndrome?

Rebecca Voelker, MSJ

Abstract Full Text

free access

JAMA. 2024;331(12):1070. doi:10.1001/jama.2023.19100

This JAMA Patient Page describes Cushing syndrome and its signs, symptoms, diagnosis, and treatment.

Comment & Response

Updated Treatment Recommendation on Use of Cabotegravir and Rilpivirine for People With HIV From the IAS-USA Guidelines Panel

Paul E. Sax, MD; Melanie A. Thompson, MD; Michael S. Saag, MD; et al.

Abstract Full Text

free access

JAMA. 2024;331(12):1060-1061. doi:10.1001/jama.2024.2985

AI in Medicine

Health AI Assurance Laboratories

William W. Stead, MD; Constantin Aliferis, MD, MS, PhD

Minton Truitt Cooper, MD

Abstract Full Text

JAMA. 2024;331(12):1064-1065. doi:10.1001/jama.2024.1333

May 2024 - July 1883

Decade

Year

Issue

March 26, 2024, Vol 331, No. 12, Pages 993-1070

AI in Medicine

AI in Medicine

AI in Medicine

Latest from the USPSTF